Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implementation of a Comprehensive Intervention on Hypertension（HTN） and Type 2 Diabetes Mellitus（DM） at PHC Level: a Hybrid Type II Cluster-controlled Multisite Effectiveness-implementation Trial

NCT05353699 is registered in ClinicalTrials.gov with National Center for Chronic and Noncommunicable Disease Control and Prevention, China CDC as lead sponsor.

NCT NCT05353699
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05353699 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implementation of a Comprehensive Intervention on Hypertension（HTN） and Type 2 Diabetes Mellitus（DM） at PHC Level: a Hybrid Type II Cluster-controlled Multisite Effectiveness-implementation Trial
Lead sponsor
National Center for Chronic and Noncommunicable Disease Control and Prevention, China CDC
Phase
Not applicable
Overall status
Unknown status
Start date
May 1, 2022
Completion date
January 31, 2023
Enrollment
12,648 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2, hypertension